Dementia  >>  memantine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

10 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT00234637: Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Completed
4
204
Europe
Rivastigmine, memantine
Novartis
Alzheimer's Disease
06/05
06/05
NCT01921972: The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

Completed
4
232
Europe
Galantamine CR, Memantine, Placebo
Charite University, Berlin, Germany, German Federal Ministry of Education and Research
Alzheimer's Disease
11/08
05/09
NCT00855686: Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies

Completed
4
199
Europe
Memantine, Ebixa®, Placebo
H. Lundbeck A/S
Parkinson's Disease Dementia, Dementia With Lewy Bodies
12/08
01/09
NCT00862940: A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease

Completed
4
277
Europe
Memantine, Ebixa®, Placebo
H. Lundbeck A/S
Alzheimer's Disease
02/09
04/09
MemAP, NCT00649220 / 2007-004489-41: Memantine and Antipsychotics Use

Terminated
4
19
Europe
Memantine
Merz Pharmaceuticals GmbH
Alzheimer's Disease
05/09
06/09
NCT00768261: Corticolimbic Degeneration and Treatment of Dementia

Completed
4
39
NA
Memantine (Namenda®), Namenda, Donepezil (Aricept®), Aricept
Washington University School of Medicine, Northwestern University
Dementia
10/09
10/09
NCT00401167: Memantine for Agitation and Aggression in Severe Alzheimer's Disease

Completed
4
31
Canada
memantine
Sunnybrook Health Sciences Centre, Lundbeck Canada Inc.
Alzheimer's Disease
01/10
01/10
FOGG-I, NCT01108029 / 2008-008210-38: Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease

Completed
4
28
Europe
memantine, EBIXA, placebo
University Hospital, Lille
Parkinson's Disease, Gait Disorders, Neurologic
09/10
10/10
NCT00800709: Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Completed
4
26
RoW
Memantine, Memantine hydrochloride
Shanghai Mental Health Center, H. Lundbeck A/S
Alzheimer's Disease
10/10
10/10
NCT02553928: Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Completed
4
62
RoW
Memantine (once daily), Lu 00-800, Ebixa ®, Ebix ®, Memantine (twice daily)
H. Lundbeck A/S
Alzheimer Dementia (AD)
07/16
07/16

Download Options